Long‐term persistence of anti‐HAV antibody conferred by a single dose of live‐attenuated hepatitis A vaccine: Results from 17‐year follow‐up-Reference-Cited by-同舟云学术

Long‐term persistence of anti‐HAV antibody conferred by a single dose of live‐attenuated hepatitis A vaccine: Results from 17‐year follow‐up

Published:2021-08-28 Issue:12 Volume:28 Page:1751-1755
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Chen Ying¹,Zhao Yu‐Liang²,Hao Zhi‐Yong³,Zhang Xin‐Jiang³,Ma Jing‐Chen²,Zhang Zhi‐Yong³,Zhang Yan‐Hong³,Zhao Gan¹,Qiu Chao¹,Kilgore Paul E.⁴,Wang Song‐Mei⁵,Wang Xuan‐Yi¹⁶⁷^ORCID

Affiliation:

1. Key Laboratory of Medical Molecular Virology of MoE & MoH and Institutes of Biomedical Sciences Fudan University Shanghai China

2. Hebei Province Center for Disease Control and Prevention Shijiazhuang Hebei China

3. Zhengding County Center for Disease Control and Prevention Zhengding Hebei China

4. Eugene Applebaum College of Pharmacy and Health Sciences Wayne State University Detroit Michigan USA

5. Laboratory of Molecular Biology Training Center of Medical Experiments School of Basic Medical Sciences Fudan University Shanghai China

6. Children's Hospital Fudan University Shanghai China

7. Shanghai Institute of Infectious Disease and Biosecurity Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13602

Reference14 articles.

1. Live attenuated hepatitis A vaccines developed in China

2. Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention

3. Dose-response analyses using restricted cubic spline functions in public health research

4. Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine

5. Long-term antibody persistence after vaccination with a 2-dose Havrix™ (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study;The Lancet Infectious Diseases;2024-08